HCN4: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Hyperpolarization-activated ion channel that are permeable to Na(+) and K(+) ions with very slow activation and inactivation.
- Drugs that act on it: 2
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Dronedarone | Approved | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker | Blocker | Boxed warning |
| Ivabradine | — | Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker | Blocker | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Sick sinus syndrome 2, autosomal dominant
- 0.73
- Heart failure
- 0.60
- Brugada syndrome 8
- 0.59
- Cardiac arrhythmia
- 0.58
- Angina pectoris
- 0.57
- Atrial flutter
- 0.52
- Abnormality of the cardiovascular system
- 0.52
- Familial sick sinus syndrome
- 0.47
- Left ventricular noncompaction cardiomyopathy
- 0.44
- Sinoatrial node disorder
- 0.43
- Congestive heart failure
- 0.41
Drugs and mechanisms are from ChEMBL CHEMBL1250417 (CC BY-SA 3.0). Gene name, function (UniProt Q9Y3Q4, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets